Atranorin is a novel potential candidate drug for treating myelodysplastic syndrome-Reference-Cited by-同舟云学术

Atranorin is a novel potential candidate drug for treating myelodysplastic syndrome

Published:2024-04-05 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Semenov Konstantin N.¹,Prokopiev Ilya A.²,Petukhova Natalya V.¹,Kremenetskaya Uliana A.³,Senichkina Dina A.¹,Epifanovskaya Olga S.¹,Rumiantsev Andrei M.³,Andoskin Pavel A.¹,Ageev Sergei V.¹,Anufrikov Yurii A.³,Zakharov Egor E.¹,Moiseev Ivan S.¹,Sharoyko Vladimir V.¹

Affiliation:

1. Pavlov First Saint Petersburg State Medical University

2. Komarov Botanical Institute of the Russian Academy of Sciences

3. Saint Petersburg State University

Abstract

This work is devoted to the study of biocompatibility, cyto- and genotoxicity, mechanism of action and prospects for the use of atranorin, which is an AKT kinase inhibitor, for the treatment of myelodysplastic syndrome. Atranorin was isolated by preparative flash chromatography; identification was carried out by UV, IR, and NMR spectroscopy, mass spectrometry, and elemental analysis. Biocompatibility studies included studies of haemocompatibility, genotoxicity, antioxidant activity, cytotoxicity against ECV340 and HEK293 cell lines. Computer modelling of the interaction of atranorin with AKT kinase was carried out using docking followed by molecular dynamics of the resulting complexes; the ADMET properties of atranorin were also calculated. Flow cytometry included analysis of the expression level of PD-L1 and TIM-3 in the presence of atranorin on THP-1, Mono-Mac-1 and KG-1 cell lines, as well as human bone marrow cells.

Publisher

Research Square Platform LLC

Reference68 articles.

1. Elix, J. A. & Stocker-Wörgötter, E. Biochemistry and secondary metabolites. in Lichen Biology 104–133 (Cambridge University Press, 2008). doi:10.1017/CBO9780511790478.008.

2. Hawksworth, D. L. Supplement to “Chemical and Botanical Guide to Lichen Products”. By Chicita F. Culberson. The American Bryological and Lichenological Society (Reprinted from Bryologist, 73: (177–377). 1970. Price US $4.00. The Lichenologist 5, 179–179 (1971).

3. Secondary metabolism in the lichen symbiosis;Calcott MJ;Chem Soc Rev,2018

4. 1880–1975) and His Studies on Lichenology and Chemistry of Lichen Metabolites on JSTOR;Shibata S;Bryologist,2000

5. Atranorin - An Interesting Lichen Secondary Metabolite;Studzinska-Sroka E;Mini-Reviews in Medicinal Chemistry,2017